TL

Trebor Lawton

Co-Founder & Chief Technology Officer

Abyssinia Biologics

Abyssinia Biologics Pipeline

DrugIndicationPhase
ABY-1125Alzheimer's DiseasePreclinical
ABY-1220Alzheimer's DiseasePreclinical
Preventative VaccineAlzheimer's Disease (Prevention)Preclinical
Oligomer Diagnostic BiomarkersAlzheimer's Disease DiagnosisPreclinical/Research